TheraSense FreeStyle
This article was originally published in The Gray Sheet
Executive Summary
Blood glucose monitor launched Aug. 1 is "virtually pain-free," since it uses only 0.3 microliters of blood taken from the arm and obviates the need for larger fingertip blood samples, the company claims. Cleared via 510(k) in January, the device uses "less [blood] than other blood glucose monitoring systems on the market," according to the Alameda, California firm. The FreeStyle meter uses coulometric technology to minimize the needed sample size and retails for $75; test strips used with the meter are priced at $39 for 50 or $69 for 100
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.